2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and tcv 309

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with tcv 309 in 1 studies

Compound Research Comparison

Studies (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)	Trials (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)	Recent Studies (post-2010) (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran)	Studies (tcv 309)	Trials (tcv 309)	Recent Studies (post-2010) (tcv 309)
63	0	0	68	2	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S	1

Other Studies

1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and tcv 309

Article	Year
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2 Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles	1992

Article

Year

Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.

The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles

1992